2m 2m 2m 2m 2m 2m 2m
BIOAGE LABS (BIOA)
NASDAQ
$6.70-$0.11 (-1.66%)
Price as of Oct 02, 2026 6:31 PM EDT- $312.6MMarket Cap
- 15.42%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOAGE LABS (BIOA)
$6.70-$0.11 (-1.66%)
BIOA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.81 | ||
Change | -$0.28 (-3.95%) | ||
Open | $7.06 | ||
High | $7.17 | ||
Low | $6.70 | ||
Previous Close | $7.09 | ||
Volume | 591,113 | ||
30-Day Average Volume | 680,448 | ||
1-Week Change | -5.55% | ||
1-Month Change | -28.47% | ||
1-Year Change | 15.42% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.9M | ||
Total Assets | $396.9M | ||
Market Cap | $312.6M | ||
Enterprise Value | $238.6M | ||
Period: QTR TTM FY | |||
Revenue | $2.5M | ||
Net Income | -$26.1M | ||
Free Cash Flow | -$19.6M | ||
EBIT | -$26.1M | ||
EBITDA | -$26.1M | ||
Net Working Capital | $311.1M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 97 | ||
P/B | 1 | ||
P/E | -12 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue